The Cheesecake Factory Incorporated Announces Major Strides Toward Eliminating Gestation Crates in its Pork Supply

The Cheesecake Factory Incorporated (NASDAQ: CAKE) has announced progress toward its longstanding goal of eliminating gestation crates from its pork supply. As detailed in its recently published 2021 Corporate Social Responsibility Report, the company is projecting that it will transition 75% of its U.S. pork supply to be fully gestation crate-free by the end of 2022, accomplished through a unique partnership with its strategic suppliers.

Local Non-Profit Group Trying to Halt Construction of New Hog Plant in Sioux Falls

Locally-owned Wholestone Farms — whose board chairman insists the facility’s look and odor will not be a hazard to the area’s quality of life — plans to employ 2,000 workers and harvest 6,000,000 hogs per year on about half of the 172 acres of land the company bought near I-229 and Benson Road.

Smithfield Foods Stops Slaughtering Pigs at U.S. Hometown Plant

July 16, 2021 Tom Polansek, Reuters

Smithfield Foods, the world’s largest pork processor, has stopped slaughtering pigs in the United States’ so-called ham capital, where the company was founded 85 years ago.

Maple Leaf Foods Inc. to Purchase Four Saskatchewan Pig Farms

June 30, 2021 Maple Leaf Foods,

Maple Leaf Foods Inc. announced that it has reached an agreement to purchase four pig farms in central Saskatchewan from a group of companies known as Polar Pork. The acquisition will enhance Maple Leaf Foods’ overall pig supply and substantially increase its pig production capacity in the province.

FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs for Both Human Food

December 17, 2020 FDA

The U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics. This is the first IGA in an animal that the FDA has approved for both human food consumption and as a source for potential therapeutic uses.